Quantification and reliability of [11C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung — a test-retest PET study in control subjects
Abstract Background The radioligand [11C]VC-002 was introduced in a small initial study long ago for imaging of muscarinic acetylcholine receptors (mAChRs) in human lungs using positron emission tomography (PET). The objectives of the present study in control subjects were to advance the methodology...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-06-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13550-020-00634-0 |
id |
doaj-b57a1b395ada441a9bd3f59c5762420f |
---|---|
record_format |
Article |
spelling |
doaj-b57a1b395ada441a9bd3f59c5762420f2020-11-25T02:51:58ZengSpringerOpenEJNMMI Research2191-219X2020-06-0110111310.1186/s13550-020-00634-0Quantification and reliability of [11C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung — a test-retest PET study in control subjectsZsolt Cselényi0Aurelija Jucaite1Cecilia Kristensson2Per Stenkrona3Pär Ewing4Andrea Varrone5Peter Johnström6Magnus Schou7Ana Vazquez-Romero8Mohammad Mahdi Moein9Martin Bolin10Jonathan Siikanen11Pär Grybäck12Bengt Larsson13Christer Halldin14Ken Grime15Ulf G. Eriksson16Lars Farde17PET Science Centre, Precision Medicine, R&D, AstraZenecaPET Science Centre, Precision Medicine, R&D, AstraZenecaBioPharmaceuticals R&D, AstraZenecaDepartment of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County CouncilBioPharmaceuticals R&D, AstraZenecaDepartment of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County CouncilPET Science Centre, Precision Medicine, R&D, AstraZenecaPET Science Centre, Precision Medicine, R&D, AstraZenecaDepartment of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County CouncilDepartment of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County CouncilDepartment of Medical Radiation Physics and Nuclear Medicine, Karolinska University HospitalDepartment of Medical Radiation Physics and Nuclear Medicine, Karolinska University HospitalDepartment of Medical Radiation Physics and Nuclear Medicine, Karolinska University HospitalBioPharmaceuticals R&D, AstraZenecaDepartment of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County CouncilBioPharmaceuticals R&D, AstraZenecaBioPharmaceuticals R&D, AstraZenecaPET Science Centre, Precision Medicine, R&D, AstraZenecaAbstract Background The radioligand [11C]VC-002 was introduced in a small initial study long ago for imaging of muscarinic acetylcholine receptors (mAChRs) in human lungs using positron emission tomography (PET). The objectives of the present study in control subjects were to advance the methodology for quantification of [11C]VC-002 binding in lung and to examine the reliability using a test-retest paradigm. This work constituted a self-standing preparatory step in a larger clinical trial aiming at estimating mAChR occupancy in the human lungs following inhalation of mAChR antagonists. Methods PET measurements using [11C]VC-002 and the GE Discovery 710 PET/CT system were performed in seven control subjects at two separate occasions, 2–19 days apart. One subject discontinued the study after the first measurement. Radioligand binding to mAChRs in lung was quantified using an image-derived arterial input function. The total distribution volume (V T) values were obtained on a regional and voxel-by-voxel basis. Kinetic one-tissue and two-tissue compartment models (1TCM, 2TCM), analysis based on linearization of the compartment models (multilinear Logan) and image analysis by data-driven estimation of parametric images based on compartmental theory (DEPICT) were applied. The test-retest repeatability of V T estimates was evaluated by absolute variability (VAR) and intraclass correlation coefficients (ICCs). Results The 1TCM was the statistically preferred model for description of [11C]VC-002 binding in the lungs. Low VAR (< 10%) across analysis methods indicated good reliability of the PET measurements. The V T estimates were stable after 60 min. Conclusions The kinetic behaviour and good repeatability of [11C]VC-002 as well as the novel lung image analysis methodology support its application in applied studies on drug-induced mAChR receptor occupancy and the pathophysiology of pulmonary disorders. Trial registration ClinicalTrials.gov identifier: NCT03097380 , registered: 31 March 2017.http://link.springer.com/article/10.1186/s13550-020-00634-0Muscarinic acetylcholine receptorsPositron emission tomography[11C]VC-002Test-retestLungs |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zsolt Cselényi Aurelija Jucaite Cecilia Kristensson Per Stenkrona Pär Ewing Andrea Varrone Peter Johnström Magnus Schou Ana Vazquez-Romero Mohammad Mahdi Moein Martin Bolin Jonathan Siikanen Pär Grybäck Bengt Larsson Christer Halldin Ken Grime Ulf G. Eriksson Lars Farde |
spellingShingle |
Zsolt Cselényi Aurelija Jucaite Cecilia Kristensson Per Stenkrona Pär Ewing Andrea Varrone Peter Johnström Magnus Schou Ana Vazquez-Romero Mohammad Mahdi Moein Martin Bolin Jonathan Siikanen Pär Grybäck Bengt Larsson Christer Halldin Ken Grime Ulf G. Eriksson Lars Farde Quantification and reliability of [11C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung — a test-retest PET study in control subjects EJNMMI Research Muscarinic acetylcholine receptors Positron emission tomography [11C]VC-002 Test-retest Lungs |
author_facet |
Zsolt Cselényi Aurelija Jucaite Cecilia Kristensson Per Stenkrona Pär Ewing Andrea Varrone Peter Johnström Magnus Schou Ana Vazquez-Romero Mohammad Mahdi Moein Martin Bolin Jonathan Siikanen Pär Grybäck Bengt Larsson Christer Halldin Ken Grime Ulf G. Eriksson Lars Farde |
author_sort |
Zsolt Cselényi |
title |
Quantification and reliability of [11C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung — a test-retest PET study in control subjects |
title_short |
Quantification and reliability of [11C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung — a test-retest PET study in control subjects |
title_full |
Quantification and reliability of [11C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung — a test-retest PET study in control subjects |
title_fullStr |
Quantification and reliability of [11C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung — a test-retest PET study in control subjects |
title_full_unstemmed |
Quantification and reliability of [11C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung — a test-retest PET study in control subjects |
title_sort |
quantification and reliability of [11c]vc - 002 binding to muscarinic acetylcholine receptors in the human lung — a test-retest pet study in control subjects |
publisher |
SpringerOpen |
series |
EJNMMI Research |
issn |
2191-219X |
publishDate |
2020-06-01 |
description |
Abstract Background The radioligand [11C]VC-002 was introduced in a small initial study long ago for imaging of muscarinic acetylcholine receptors (mAChRs) in human lungs using positron emission tomography (PET). The objectives of the present study in control subjects were to advance the methodology for quantification of [11C]VC-002 binding in lung and to examine the reliability using a test-retest paradigm. This work constituted a self-standing preparatory step in a larger clinical trial aiming at estimating mAChR occupancy in the human lungs following inhalation of mAChR antagonists. Methods PET measurements using [11C]VC-002 and the GE Discovery 710 PET/CT system were performed in seven control subjects at two separate occasions, 2–19 days apart. One subject discontinued the study after the first measurement. Radioligand binding to mAChRs in lung was quantified using an image-derived arterial input function. The total distribution volume (V T) values were obtained on a regional and voxel-by-voxel basis. Kinetic one-tissue and two-tissue compartment models (1TCM, 2TCM), analysis based on linearization of the compartment models (multilinear Logan) and image analysis by data-driven estimation of parametric images based on compartmental theory (DEPICT) were applied. The test-retest repeatability of V T estimates was evaluated by absolute variability (VAR) and intraclass correlation coefficients (ICCs). Results The 1TCM was the statistically preferred model for description of [11C]VC-002 binding in the lungs. Low VAR (< 10%) across analysis methods indicated good reliability of the PET measurements. The V T estimates were stable after 60 min. Conclusions The kinetic behaviour and good repeatability of [11C]VC-002 as well as the novel lung image analysis methodology support its application in applied studies on drug-induced mAChR receptor occupancy and the pathophysiology of pulmonary disorders. Trial registration ClinicalTrials.gov identifier: NCT03097380 , registered: 31 March 2017. |
topic |
Muscarinic acetylcholine receptors Positron emission tomography [11C]VC-002 Test-retest Lungs |
url |
http://link.springer.com/article/10.1186/s13550-020-00634-0 |
work_keys_str_mv |
AT zsoltcselenyi quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT aurelijajucaite quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT ceciliakristensson quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT perstenkrona quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT parewing quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT andreavarrone quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT peterjohnstrom quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT magnusschou quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT anavazquezromero quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT mohammadmahdimoein quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT martinbolin quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT jonathansiikanen quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT pargryback quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT bengtlarsson quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT christerhalldin quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT kengrime quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT ulfgeriksson quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects AT larsfarde quantificationandreliabilityof11cvc002bindingtomuscarinicacetylcholinereceptorsinthehumanlungatestretestpetstudyincontrolsubjects |
_version_ |
1724732124635856896 |